AIM:FDBK

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Market Cap

UK£7.7m

Last Updated

2021/08/01 17:51 UTC

Data Sources

Company Financials

Executive Summary

Feedback plc, a medical imaging technology company, provides software and systems to those working in the field of medical imaging. More Details


Snowflake Analysis

Flawless balance sheet and overvalued.

Share Price & News

How has Feedback's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: FDBK is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: FDBK's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of UK stocks.


Market Performance


7 Day Return

-14.7%

FDBK

2.2%

GB Healthcare Services

0.3%

GB Market


1 Year Return

-45.3%

FDBK

42.6%

GB Healthcare Services

22.5%

GB Market

Return vs Industry: FDBK underperformed the UK Healthcare Services industry which returned 42.6% over the past year.

Return vs Market: FDBK underperformed the UK Market which returned 22.5% over the past year.


Shareholder returns

FDBKIndustryMarket
7 Day-14.7%2.2%0.3%
30 Day-27.5%4.4%-0.7%
90 Day-44.2%-9.0%1.5%
1 Year-45.3%-45.3%44.9%42.6%27.8%22.5%
3 Year-64.2%-64.2%35.7%29.0%13.3%0.9%
5 Year-35.6%-35.6%71.7%56.3%39.6%13.2%

Long-Term Price Volatility Vs. Market

How volatile is Feedback's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Feedback undervalued compared to its fair value and its price relative to the market?

1.17x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate FDBK's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate FDBK's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: FDBK is unprofitable, so we can't compare its PE Ratio to the European Healthcare Services industry average.

PE vs Market: FDBK is unprofitable, so we can't compare its PE Ratio to the UK market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate FDBK's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: FDBK is good value based on its PB Ratio (1.2x) compared to the GB Healthcare Services industry average (6.4x).


Future Growth

How is Feedback forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

28.2%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Feedback has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Feedback performed over the past 5 years?

-26.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: FDBK is currently unprofitable.

Growing Profit Margin: FDBK is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: FDBK is unprofitable, and losses have increased over the past 5 years at a rate of 26.6% per year.

Accelerating Growth: Unable to compare FDBK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: FDBK is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (24.9%).


Return on Equity

High ROE: FDBK has a negative Return on Equity (-20.12%), as it is currently unprofitable.


Financial Health

How is Feedback's financial position?


Financial Position Analysis

Short Term Liabilities: FDBK's short term assets (£4.4M) exceed its short term liabilities (£395.0K).

Long Term Liabilities: FDBK has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: FDBK is debt free.

Reducing Debt: FDBK has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: FDBK has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: FDBK has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 35.9% each year.


Dividend

What is Feedback current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate FDBK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate FDBK's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if FDBK's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if FDBK's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of FDBK's dividend in 3 years as they are not forecast to pay a notable one for the UK market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average board tenure


CEO

Tom Oakley (33 yo)

2.25yrs

Tenure

UK£170,000

Compensation

Dr. Thomas James Oakley, also known as Tom,BM(Hons) BSc (Hons), has been Chief Executive Officer of Feedback plc since April 9, 2019 and Director since October 2019. Dr Oakley has been Chief Executive Offi...


CEO Compensation Analysis

Compensation vs Market: Tom's total compensation ($USD236.40K) is about average for companies of similar size in the UK market ($USD324.01K).

Compensation vs Earnings: Tom's compensation has increased whilst the company is unprofitable.


Board Members

Experienced Board: FDBK's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Feedback plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Feedback plc
  • Ticker: FDBK
  • Exchange: AIM
  • Founded: 1958
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: UK£7.735m
  • Shares outstanding: 1.07b
  • Website: https://fbkmed.com/feedback-plc

Number of Employees


Location

  • Feedback plc
  • Health Foundry
  • Canterbury House
  • London
  • Greater London
  • SE1 7LL
  • United Kingdom

Listings


Biography

Feedback plc, a medical imaging technology company, provides software and systems to those working in the field of medical imaging. Its products include TexRAD, a software tool, which extracts and quantifi...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/08/01 17:51
End of Day Share Price2021/07/30 00:00
Earnings2020/11/30
Annual Earnings2020/05/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.